Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.810
+0.110 (2.34%)
At close: Dec 17, 2025, 4:00 PM EST
4.980
+0.170 (3.53%)
After-hours: Dec 17, 2025, 5:24 PM EST
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $615.03 million as of December 17, 2025. Its market cap has decreased by -26.88% in one year.
Market Cap
615.03M
Enterprise Value
378.12M
1-Year Change
-26.88%
Ranking
Category
Stock Price
$4.81
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $615.03M, a decrease of -72.80%. That is a compound annual growth rate of -25.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 600.96M | -28.11% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | 2.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.07B |
| Johnson & Johnson | 516.00B |
| AbbVie | 401.99B |
| UnitedHealth Group | 308.98B |
| AstraZeneca | 282.48B |
| Novartis AG | 258.61B |
| Merck & Co. | 248.85B |
| Abbott Laboratories | 223.39B |